共 50 条
iPLEDGE Weaknesses: Is It Time to Address the Flaws?
被引:0
|作者:
Cyrulnik, Amanda A.
[1
,2
]
Gewirtzman, Aron J.
[1
,3
]
Paz, Karin Blecher
[1
]
Glick, Jaimie B.
[2
]
Anam, Anika K.
[2
]
Carrasco, Daniel A.
[3
]
Shalita, Alan R.
[2
]
Cohen, Steven R.
[1
]
机构:
[1] Albert Einstein Coll Med, Unified Div Dermatol, Bronx, NY 10467 USA
[2] SUNY Downstate Dept Dermatol, Brooklyn, NY USA
[3] Austin Dermatol Associates, Austin, TX USA
关键词:
ELECTRONIC MEDICAL-RECORD;
ISOTRETINOIN;
D O I:
暂无
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Background: The observance during acne follow-ups that information stored within iPLEDGE was discordant with medical charts prompted this study. Objective: To evaluate the information acquired and stored within iPLEDGE as it compares to medical charts with a goal of assessing the efficacy of iPLEDGE as a database. Methods: This is a multicenter retrospective chart review analyzing congruence and discrepancies between medical chart documentation and iPLEDGE data for all patients who received at least a single dose of isotretinoin from the primary investigators between January 2006 and November 2010. Results: A total of 357 charts were analyzed. Overall congruence between medical chart documentation and iPLEDGE data was observed in only 73.1 % of cases. The discrepancy (N=96) was due to a missed dose (prescription recorded in chart but not in iPLEDGE) in 81.4% of cases, or an addition (medication dispensed per iPLEDGE without corresponding chart documentation) in the remainder of cases. Of note, several charts had multiple discrepancies (N=249 total discrepancies). Limitations: Retrospective chart review study. Conclusion: Given the large percentage of discordant data, our findings question the efficacy of the iPLEDGE system, which is designed to monitor every dispensed isotretinoin dose.
引用
收藏
页码:97 / 102
页数:6
相关论文